05/05
Headlines

Kristen Barton

Kristen Barton is a managing director and co-director of investment research. Kristen is also a senior research analyst focusing on agriculture & biotech companies. Prior to joining Tech Insider in 2010, Barton worked in equity research at RBC Capital Markets in Minneapolis, MN and Edward Jones in St. Louis, Mo. She was recognized for her stock picking in the 2012 Wall Street Journal "Best on the Street" publication.

Gilead Sciences GILD NASDAQ:GILD

Services Sector Unusual Volume: Vringo (NASDAQ:VRNG), Cardtronics, Inc. (NASDAQ:CATM), ITT Educational Services (NYSE:ESI), EnerNOC, Inc. (NASDAQ:ENOC), ENGlobal Corp (NASDAQ:ENG)

Kristen Barton03 mins

Vringo Inc. (NASDAQ:VRNG), up 14 cents to $3.41. The software developer could be a big beneficiary of a Supreme Court ruling in its fight with Google over patent infringement. Vringo, Inc. (NASDAQ:VRNG) stock performance was 4.28% in last session and finished the day at $3.41. Traded volume was 6.45million shares in the last session and…

Read More
FB Nasdaq FB Facebook

Hot Watch List: Plug Power (NASDAQ:PLUG), Companhia Energetica Minas Gerais (NYSE:CIG), FuelCell Energy (NASDAQ:FCEL), SINA (NASDAQ:SINA), Qihoo 360 Technology (NYSE:QIHU)

Kristen Barton03 mins

Plug Power Inc. (NASDAQ:PLUG) on May 14 reported its 2014 first quarter results. Total revenue for the first quarter of 2014 was $5.6 million, comprised of $3.2 million for product revenue, $2.1 million for service revenue and $0.3 million for research and development (R&D) contract revenue. This compares to total revenue of $6.4 million in…

Read More
Gilead Sciences GILD NASDAQ:GILD

Hot Biotech Watch List: InterMune Inc (NASDAQ:ITMN), Merrimack Pharmaceuticals (NASDAQ:MACK), China Biologic Products (NASDAQ:CBPO), VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA)

Kristen Barton03 mins

InterMune, Inc. (NASDAQ:ITMN) on 27 May 2014 announced that it has resubmitted its pirfenidone New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in May 2010. Pirfenidone is being developed for the treatment of adult patients with idiopathic pulmonary fibrosis (IPF). InterMune Inc…

Read More
Gilead Sciences GILD NASDAQ:GILD

Gainers to Watch: Apple Inc. (NASDAQ:AAPL), 58.com Inc (ADR) (NYSE:WUBA), China Mobile Games & Entnmnt (NASDAQ:CMGE), ParkerVision (NASDAQ:PRKR), Imperva (NYSE:IMPV)

Kristen Barton03 mins

Apple Inc (NASDAQ:AAPL) had been in talks about a possible purchase of the stake in Renesas SP Driver in what was seen as a potential move to shore up its global supply chain, but the sources said those talks failed to make progress and Renesas had narrowed its consideration to Synaptics. Apple Inc. (NASDAQ:AAPL) stock…

Read More
Gilead Sciences GILD NASDAQ:GILD

Consumer Goods Active Movers: Apple Inc. (NASDAQ:AAPL), Ford Motor Company (NYSE:F), General Motors (NYSE:GM), The Coca-Cola (NYSE:KO), Mondelez International (NASDAQ:MDLZ)

Kristen Barton03 mins

Apple Inc (NASDAQ:AAPL) supplier Foxconn Technology Group will buy a stake in Taiwanese mobile telecoms operator Asia Pacific Telecom for T$11.6 billion ($390 million) in a deal that would expand its presence in Taiwan’s fledgling 4G telecoms market. Apple Inc. (NASDAQ:AAPL) stock performance was 1.13% in last session and finished the day at $614.13. Traded…

Read More

Notable Movers: ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), PTC Therapeutics, Inc. (NASDAQ:PTCT), Orexigen Therapeutics, Inc. (NASDAQ:OREX), CytRx Corporation (NASDAQ:CYTR), ZIOPHARM Oncology (NASDAQ:ZIOP)

Kristen Barton03 mins

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) presented results from a global, multi-center, open-label, comparator-controlled phase II study in patients undergoing total knee replacement surgery or total knee arthroplasty (TKA). Two doses of ISIS-FXIRx (200mg, 300mg) were compared to Sanofi’s Lovenox (enoxaparin). ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock performance was 11.26% in last session and finished the day at…

Read More